Journal article
Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial.
- Abstract:
-
The MIST2 trial showed that combined intrapleural use of tissue plasminogen activator (t-PA) and DNase was effective when compared to single agents or placebo. However, the treatment costs are significant and overall cost-effectiveness of combined therapy remains unclear.An economic evaluation of the MIST2 trial was performed to assess the cost-effectiveness of combined therapy. Costs included were those related to study medications, initial hospital stay, and subsequent hospitalisations. Out...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 467.4KB)
-
- Publisher copy:
- 10.1183/13993003.01550-2018
Authors
Bibliographic Details
- Publisher:
- European Respiratory Society Publications Publisher's website
- Journal:
- European respiratory journal Journal website
- Volume:
- 54
- Issue:
- 2019
- Article number:
- 1801550
- Publication date:
- 2019-05-16
- Acceptance date:
- 2019-05-01
- DOI:
- EISSN:
-
1399-3003
- ISSN:
-
0903-1936
- Pmid:
-
31097519
Item Description
- Language:
- English
- Pubs id:
-
pubs:999408
- UUID:
-
uuid:a959ef24-0ec4-45c6-99d5-885d7af6eef5
- Local pid:
- pubs:999408
- Source identifiers:
-
999408
- Deposit date:
- 2019-05-27
Terms of use
- Copyright holder:
- ERS
- Copyright date:
- 2019
- Rights statement:
- Copyright © ERS 2019
- Notes:
- This is the accepted manuscript version of the article. The final version is available from ERS Publications at: http://dx.doi.org/10.1183/13993003.01550-2018
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record